Unifying Clinical Trial Systems Without Study Disruption: A Practical, Phased Approach
Ellie Brightman August 27, 2026
A Practical, Phased Approach to Technology Consolidation
Read More »
Successful Trial Scaling: How to Build Trials That Can Grow Without Breaking
Ellie Brightman August 15, 2026
Many studies begin with a strong scientific objective and a well-intentioned protocol. On paper, the trial may look organized. The visit schedule is defined. The eligibility criteria are written. The data collection plan is approved. The study team understands the immediate goal. But scaling exposes what planning can miss. As more sites are added, more users need access, more safety
7 Technology Trends Shaping Clinical Trials in 2026
Ellie Brightman July 30, 2026
Clinical research has never had more technology available. Yet many organizations continue to face the same challenges they faced a decade ago: lengthy study startup timelines, disconnected systems, protocol amendments, increasing regulatory complexity, and growing pressure to deliver results faster without sacrificing quality.
Enlighten Clinical Solutions Selected for AAO 2026 Innovation Hub
Ellie Brightman July 8, 2026
Enlighten Clinical Solutions has been selected to showcase and present at the American Academy of Ophthalmology (AAO) 2026 Innovation Hub in New Orleans. The Innovation Hub recognizes emerging companies and technologies that are helping advance ophthalmology and clinical research. During the event, CEO Jim Harris will present Enlighten’s vision for improving clinical trial execution through connected, modern study technology. The
Keeping Clinical Trials on Track: Practical Strategies for Clinical Research Associates
Ellie Brightman July 1, 2026
Focus In: Strategies for Clinical Research Associates Clinical trials rarely fall off track because of one major issue. Sometimes a document is filed late, or a query lingers longer than expected. A process can look compliant on paper and then go awry in practice. And much like a plane that’s a few degrees off course, the deviation may seem minor
When Portfolio Reviews Become Reconciliation Exercises
Ellie Brightman June 15, 2026
Portfolio reviews are meant to provide clarity. They are designed to give sponsors a clear, shared understanding of how their clinical trials are progressing, where risks are emerging, and what decisions need to be made next. At their best, portfolio reviews align leadership, clinical operations, and data teams around a common picture of reality. But for many sponsors, portfolio reviews
The Hidden Cost of Running EDC, eTMF, and CTMS as Separate Systems
Ellie Brightman June 1, 2026
In many sponsor organizations, Electronic Data Capture (EDC), electronic Trial Master File (eTMF), and Clinical Trial Management Systems (CTMS) are treated as distinct operational domains. Each system has its own purpose, its own workflows, and its own users. On paper, this separation can appear logical—even reassuring. Best‑in‑class tools are selected for each function, teams are trained accordingly, and responsibilities are
Why Sponsors Lose Trust in Their Trial Data (and How It Happens Gradually)
Ellie Brightman May 15, 2026
Sponsors lose trust in their trial data gradually, not all at once. Trust erodes slowly, often quietly, as small mismatches, delays, and workarounds accumulate across the life of a study. By the time trust is openly questioned, the underlying causes have usually been in place for months—or even years. Why Do Sponsors Lose Trust? This loss of confidence is rarely
Enlighten Clinical Solutions Announces Release of New CTMS Module at Eyecelerator Conference
Ellie Brightman May 1, 2026
Enlighten Clinical Solutions has launched its CTMS module, expanding the Enlighten Clinical Platform with connected tools for study oversight, site management, milestone tracking, dashboards, metrics, alerts, and operational coordination.
“Where Do Things Stand?” and Other Common Pleas from Clinical Trial Sponsors”
Ellie Brightman May 1, 2026
Sponsors often describe their challenges in clinical trials using familiar terms: oversight, timelines, compliance, and coordination. Beneath all these concerns sits a quieter but more persistent issue: portfolio visibility. Most sponsor organizations do not struggle because they lack data. They struggle because the same information exists in multiple places, in slightly different forms, at different points in time. When leadership